|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 471/20 | |
| A61K 31/4523 | |||
| A61K 31/45 | |||
| A61K 31/451 | |||
| A61P 25/06 |
| (11) | Patento numeris | 2846798 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13788067.0 |
| Europos patento paraiškos padavimo data | 2013-05-03 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-03-18 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-04-04 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2013/039373 |
| Data | 2013-05-03 |
| (87) | Numeris | WO 2013/169574 |
| Data | 2013-11-14 |
| (30) | Numeris | Data | Šalis |
| 201261644628 P | 2012-05-09 | US |
| (72) |
BELL, Ian, M., US
FRALEY, Mark, US
BIFTU, Tesfaye, US
ZHU, Cheng, US
NAIR, Anilkumar, US
MITCHELL, Helen, US
|
| (73) |
Merck Sharp & Dohme Corp.,
126 East Lincoln Avenue, Rahway, NJ 07065-0907,
US
|
| (54) | ALIPHATIC SPIROLACTAM CGRP RECEPTOR ANTAGONISTS |
| ALIPHATIC SPIROLACTAM CGRP RECEPTOR ANTAGONISTS |